2024 AWARD CATEGORIES

This award will recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Seed-Stage level. This may be an extended Seed round raise also.

This award recognises the achievements and contributions of women leaders of companies that have shown superior leadership, vision and inspiration or transformational outcomes for their business and sector as a whole during the qualifying period. It is open to leaders within European life science & health technology companies only.

This award recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Series A level. This may be an extended Series A also.

This award recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Series B level. This may be an extended Series B also.

This award recognises a company that has successfully completed a significant, impactful or transformational late stage unspecified Venture Round / Series C or beyond level. This may be a series extension.

This award recognises a company that has successfully completed a significant, impactful or transformational IPO or listing on any international exchange.

This award recognises a company that has successfully completed a significant, impactful or transformational secondary placement or follow-on equity raise / PIPE (not debt) on any international exchange.

This award recognises a European VC firm that has outperformed peers, created value and demonstrated truly outstanding investment decision making.

This award recognises the business development team from a pharma or large cap biotech company that has excelled in sourcing, executing and delivering extraordinary and transformational deals and collaborations that created significant value for consumers, company and shareholders.

• Open to all pharma companies and large cap large cap biotech companies with a market capitalisation that is €1bn or above.
• Open to all business development teams or cross-company teams on a specific deal/project

This award recognises a European Biotech (drug discovery, pre-clinical, clinical, OTM therapeutic) company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, investors, employees and the broader life science community.

This award recognises a European Medtech (device, surgical, diagnostic) company that has demonstrated superior excellence in strategy, process, focus and execution to create significant value for patients, investors, employees and the broader life science community.

This award recognises a European Healthtech (digital health, digital therapeutics, databases, applications and wearables) company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for consumer, patients, investors, employees and the broader life science community.

This award recognises the teams and organisations who have executed a truly transformational and high value creating deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value.

This award recognises the teams and organisations who have executed a truly transformational and high value creating deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value.

This award recognises the teams and organisations who have executed a truly transformational and high value M&A deal for both the company and the wider industry.

This award recognises a private company CEO that has demonstrated truly outstanding and exemplary leadership in their respective companies.

This award recognises a publicly-listed company CEO that has demonstrated truly outstanding and exemplary leadership in their respective companies.